Accordingly, targeting this lncRNA could have prognostic and therapeutic potential in CRC patients, while exosomal ADAMTS9-AS1 could be a novel diagnostic biomarker (123). This evidence concerns the gene ADAMTS9 and colorectal carcinoma.